Author of the publication

New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile

, , , , , , , and . Purinergic Signal, 3 (4): 339-46 (September 2007)Lambertucci, Catia Cristalli, Gloria Dal Ben, Diego Kachare, Dhuldeo D Bolcato, Chiara Klotz, Karl-Norbert Spalluto, Giampiero Volpini, Rosaria Netherlands Purinergic signalling Purinergic Signal. 2007 Sep;3(4):339-46. Epub 2007 Sep 19..

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Exploring potency and selectivity receptor antagonist profiles using a multilabel classification approach: the human adenosine receptors as a key study, , , , , , , , and . J Chem Inf Model, 49 (12): 2820-36 (December 2009)Michielan, Lisa Stephanie, Federico Terfloth, Lothar Hristozov, Dimitar Cacciari, Barbara Klotz, Karl-Norbert Spalluto, Giampiero Gasteiger, Johann Moro, Stefano Research Support, Non-U.S. Gov't United States Journal of chemical information and modeling J Chem Inf Model. 2009 Dec;49(12):2820-36..New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile, , , , , , , and . Purinergic Signal, 3 (4): 339-46 (September 2007)Lambertucci, Catia Cristalli, Gloria Dal Ben, Diego Kachare, Dhuldeo D Bolcato, Chiara Klotz, Karl-Norbert Spalluto, Giampiero Volpini, Rosaria Netherlands Purinergic signalling Purinergic Signal. 2007 Sep;3(4):339-46. Epub 2007 Sep 19..(3)HMRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors, , , , , , , , , and . Mol Pharmacol, 57 (5): 968-75 (May 2000)Varani, K Merighi, S Gessi, S Klotz, K N Leung, E Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Borea, P A United states Molecular pharmacology Mol Pharmacol. 2000 May;57(5):968-75..Synthesis, biological activity, and molecular modeling investigation of new pyrazolo4,3-e-1,2,4-triazolo1,5-cpyrimidine derivatives as human A(3) adenosine receptor antagonists, , , , , , , , , and . J Med Chem, 45 (4): 770-80 (February 2002)Baraldi, Pier Giovanni Cacciari, Barbara Moro, Stefano Spalluto, Giampiero Pastorin, Giorgia Da Ros, Tatiana Klotz, Karl-Norbert Varani, Katia Gessi, Stefania Borea, Pier Andrea Research Support, Non-U.S. Gov't United States Journal of medicinal chemistry J Med Chem. 2002 Feb 14;45(4):770-80..Synthesis, biological studies and molecular modeling investigation of 1,3-dimethyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro 1,2,4-triazolo 3,4-f-purines as potential adenosine receptor antagonists, , , , , , , and . Farmaco, 60 (4): 299-306 (April 2005)Pastorin, Giorgia Bolcato, Chiara Cacciari, Barbara Kachler, Sonja Klotz, Karl-Norbert Montopoli, Christian Moro, Stefano Spalluto, Giampiero Research Support, Non-U.S. Gov't Italy Farmaco (Societa chimica italiana : 1989) Farmaco. 2005 Apr;60(4):299-306..Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes, , , , , , , and . Purinergic Signal, 4 (1): 39-46 (March 2008)Bolcato, Chiara Cusan, Claudia Pastorin, Giorgia Spalluto, Giampiero Cacciari, Barbara Klotz, Karl Norbert Morizzo, Erika Moro, Stefano Netherlands Purinergic signalling Purinergic Signal. 2008 Mar;4(1):39-46. Epub 2007 Jul 25..Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure-activity profile, , , , , , and . Purinergic Signal, 3 (3): 183-93 (June 2007)Cacciari, Barbara Bolcato, Chiara Spalluto, Giampiero Klotz, Karl-Norbet Bacilieri, Magdalena Deflorian, Francesca Moro, Stefano Netherlands Purinergic signalling Purinergic Signal. 2007 Jun;3(3):183-93. Epub 2006 Nov 14..Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites, , , , , , , , , and 2 other author(s). Bioorg Med Chem, 17 (14): 5259-74 (July 2009)Michielan, Lisa Bolcato, Chiara Federico, Stephanie Cacciari, Barbara Bacilieri, Magdalena Klotz, Karl-Norbert Kachler, Sonja Pastorin, Giorgia Cardin, Riccardo Sperduti, Alessandro Spalluto, Giampiero Moro, Stefano Research Support, Non-U.S. Gov't England Bioorganic & medicinal chemistry Bioorg Med Chem. 2009 Jul 15;17(14):5259-74. Epub 2009 May 21..The application of a 3D-QSAR (autoMEP/PLS) approach as an efficient pharmacodynamic-driven filtering method for small-sized virtual library: application to a lead optimization of a human A3 adenosine receptor antagonist, , , , , , , and . Bioorg Med Chem, 14 (14): 4923-32 (July 2006)Moro, Stefano Bacilieri, Magdalena Cacciari, Barbara Bolcato, Chiara Cusan, Claudia Pastorin, Giorgia Klotz, Karl-Norbert Spalluto, Giampiero In Vitro Research Support, Non-U.S. Gov't England Bioorganic & medicinal chemistry Bioorg Med Chem. 2006 Jul 15;14(14):4923-32. Epub 2006 Mar 29..Synthesis, biological and modeling studies of 1,3-di-n-propyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro 1,2,4-triazolo 3,4-f-purines as adenosine receptor antagonists, , , , , , , and . Farmaco, 60 (8): 643-51 (August 2005)Pastorin, G Bolcato, C Cacciari, B Kachler, S Klotz, K-N Montopoli, C Moro, S Spalluto, G Research Support, Non-U.S. Gov't France Farmaco (Societa chimica italiana : 1989) Farmaco. 2005 Aug;60(8):643-51..